Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel in Total Knee Arthroplasty Pain Control
NCT02571283Phase 4Withdrawn
- Sponsor
- University of Louisville
- Start
- Oct 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by University of Louisville. Primary endpoint: Visual Pain Scale at 48 hours. Planned start Oct 2015; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02571283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02571283.